Company: BDRX
Filing Date: 2025-01-21
Form Type: 424B3
Source: 0001214659-25-000935
Chunk: 49

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-21
Form: 424B3
Chunk 49
---
if any, the Company shall permit the transfer and shall promptly instruct the Depositary (and any subsequent depositary) to issue DWAC
Shares in such name and in such denominations as specified by the Investor to effect such sale, transfer or assignment. The Company acknowledges
that a breach by it of its obligations hereunder will cause irreparable harm to the Investor. Accordingly, the Company acknowledges that
the remedy at law for a breach of its obligations under this will be inadequate and agrees, in the event of a breach
or threatened breach by the Company of the provisions of this , that the Investor shall be entitled, in addition to all
other available remedies, to seek an order and/or injunction restraining any breach and requiring immediate issuance and transfer, without
the necessity of showing economic loss and without any bond or other security being required.

| 7. | CONDITIONS TO THE COMPANY’S RIGHT TO COMMENCE |

SALES OF SHARES OF DEPOSITARY SHARES.

The right of the Company hereunder
to commence sales of the Purchase Shares as of the Commencement Date is subject to the satisfaction of each of the following conditions:

(a) The Investor shall
have executed each of the Transaction Documents and delivered the same to the Company;

(b) The Registration
Statement covering the resale of up to 35,000,000 Purchase Shares and up to 875,000 Commitment Shares shall have been declared effective
under the Securities Act by the SEC, and no stop order with respect to the Registration Statement shall be pending or threatened by the
SEC; and

(c) The representations
and warranties of the Investor shall be true and correct in all material respects as of the Execution Date and as of the Commencement
Date as though made at that time.

| 8. | CONDITIONS TO THE INVESTOR’S OBLIGATION TO PURCHASE SHARES OF DEPOSITARY SHARES. |

The obligation of the Investor
to buy Purchase Shares under this Agreement is subject to the satisfaction of each of the following conditions on or prior to the Commencement
Date and, once such conditions have been initially satisfied, there shall not be any ongoing obligation to satisfy such conditions after
the Commencement has occurred:

(a) The
Company shall have executed each of the Transaction Documents and delivered the same to the Investor;

(b) The
Commitment Fee or the Initial Commitment Shares, as applicable, shall have been paid or issued, as the case may be, to the Investor.

(c) The
Depositary Shares shall be listed or quoted